NGNA composition and methods of use
US9522158B2 · kind B2 · utility
3Cited by
5References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 13, 2014 |
| Grant date | Dec 20, 2016 |
| Priority date | — |
| Expiry date | Jan 13, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2210/0618
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the field of viral disorders, and in particular to the use of natural compounds to inhibit viruses and viral infection. Compositions comprising NGNA are provided for treating or preventing viral infections, such as those causing the common cold.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.